Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 11986777)

1.

Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo.

Pelton K, Coticchia CM, Curatolo AS, Schaffner CP, Zurakowski D, Solomon KR, Moses MA.

Am J Pathol. 2014 Jul;184(7):2099-110. doi: 10.1016/j.ajpath.2014.03.006.

2.

Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression.

Rodrigues Dos Santos C, Fonseca I, Dias S, Mendes de Almeida JC.

BMC Cancer. 2014 Feb 26;14:132. doi: 10.1186/1471-2407-14-132.

3.

LDL-cholesterol signaling induces breast cancer proliferation and invasion.

dos Santos CR, Domingues G, Matias I, Matos J, Fonseca I, de Almeida JM, Dias S.

Lipids Health Dis. 2014 Jan 15;13:16. doi: 10.1186/1476-511X-13-16.

4.

Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses.

Melvin JC, Holmberg L, Rohrmann S, Loda M, Van Hemelrijck M.

J Cancer Epidemiol. 2013;2013:823849. doi: 10.1155/2013/823849. Epub 2013 Jan 20.

5.

The risk of a subsequent cancer diagnosis after herpes zoster infection: primary care database study.

Cotton SJ, Belcher J, Rose P, K Jagadeesan S, Neal RD.

Br J Cancer. 2013 Feb 19;108(3):721-6. doi: 10.1038/bjc.2013.13. Epub 2013 Jan 29.

6.

Risk of cancer in patients exposed to gabapentin in two electronic medical record systems.

Irizarry MC, Webb DJ, Boudiaf N, Logie J, Habel LA, Udaltsova N, Friedman GD.

Pharmacoepidemiol Drug Saf. 2012 Feb;21(2):214-25. doi: 10.1002/pds.2266. Epub 2011 Dec 6.

7.

Total cholesterol and cancer risk in a large prospective study in Korea.

Kitahara CM, Berrington de González A, Freedman ND, Huxley R, Mok Y, Jee SH, Samet JM.

J Clin Oncol. 2011 Apr 20;29(12):1592-8. doi: 10.1200/JCO.2010.31.5200. Epub 2011 Mar 21.

8.

Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells.

Podhorecka M, Halicka D, Klimek P, Kowal M, Chocholska S, Dmoszynska A.

Ann Hematol. 2010 Nov;89(11):1115-24. doi: 10.1007/s00277-010-0988-z. Epub 2010 May 25.

9.

Statin use and cancer risk: a comprehensive review.

Boudreau DM, Yu O, Johnson J.

Expert Opin Drug Saf. 2010 Jul;9(4):603-21. doi: 10.1517/14740331003662620. Review.

10.

Statin use and breast cancer risk in a large population-based setting.

Boudreau DM, Yu O, Miglioretti DL, Buist DS, Heckbert SR, Daling JR.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):416-21.

11.

Elevated K-ras activity with cholestyramine and lovastatin, but not konjac mannan or niacin in lung--importance of mouse strain.

Calvert RJ, Tepper S, Kammouni W, Anderson LM, Kritchevsky D.

Biochem Pharmacol. 2006 Dec 15;72(12):1749-55. Epub 2006 Sep 3.

12.

Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts.

Zhuang L, Kim J, Adam RM, Solomon KR, Freeman MR.

J Clin Invest. 2005 Apr;115(4):959-68. Epub 2005 Mar 17.

13.

Statin therapy: having the good without the bad.

Liao JK.

Hypertension. 2004 Jun;43(6):1171-2. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk